No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Retigabine is a drug used to treat epilepsy, a neurological disorder characterized by recurrent seizures. It is a potassium channel opener, meaning it works by increasing the activity of potassium channels in the brain, which helps to reduce the frequency of seizures. Retigabine is classified as an antiepileptic drug, and is part of a larger class of drugs known as Central Nervous System (CNS) drugs. These drugs are used to treat a variety of neurological disorders, including epilepsy, Parkinson's disease, and Alzheimer's disease.
Retigabine is approved for use in the United States, Europe, and other countries. It is available in both oral and intravenous formulations. The drug is typically prescribed as an add-on therapy for patients who have not responded to other antiepileptic drugs.
Some companies in the Retigabine market include GlaxoSmithKline, Eisai, and Lundbeck. Show Less Read more
